TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NRXS

Neuraxis, Inc.

Healthcare · Biotechnology

7.40$ -2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Neuraxis, Inc. (NRXS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.4 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NRXS
Line item 2020 2021 2022 2023 2024 2025
-4.1 -2.2 -2.3 -6.7 -6.1 -6.4
0.0 0.0 0.0 0.0 0.0 0.1
0.0 0.0 0.0 0.8 1.4 0.6
-0.2 0.1 – – – –
-0.3 0.6 1.3 -0.7 0.1 0.6
0.0 0.0 0.1 0.1 0.0 0.0
0.0 0.0 -0.1 -0.1 0.0 -0.1
-0.7 0.2 3.2 2.1 4.7 -0.3
6.1 0.7 2.3 6.6 9.7 7.8
1.9 -1.6 -0.1 -0.2 3.6 1.3
-4.2 -2.2 -2.4 -6.8 -6.1 -6.5

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?